Published monthly
by RauCon,
Langer Anger 75,
69115 Heidelberg, Germany
Robotic Filling Line for Superior Quality and Flexibility in Oncology Drugs
AqVida, the German Oncology supplier, has developed a portfolio of medicines for treating the most common types of cancer and has recently stepped up production in
its ultra-modern production facility, located in Dassow, Germany. Aqvida will be available for business at euroPLX 64 Vienna.
The company’s expertise in the
development of generic oncology
products, has made AqVida a lead-
ing partner in the pharmaceutical
industry, ensuring its place as one
of the most important suppliers
for oncology products, to multiple
German and European pharma-
ceutical companies. AqVida offers
its portfolio to partner companies
on in-licensing deals based upon
MA transfers. The company has
differentiated itself from the com-
petition through short lead times,
uncompromising quality stand-
ards and a high degree of supply
flexibility – always maintaining
stock holding positions for the
majority of their most common
products.
With their new manufacturing
site, AqVida expects to increase
even further this supply flexibility.
euroPLX 64 Vienna (Austria) May 29 + 30, 2017 | Vienna Skyline
Business Developer
Vol. 13 #5 | May | 2017
This expectation, coupled to qual-
Advertisement - Position Offered
ity aspects that extend beyond
DSM Sinochem Pharmaceuticals Netherlands is expanding its global
the common GMP requirements, BD activities and therefore has the following two open positions in its
has been the dominant theme business unit drug products:
through all of the planning phases Out-Licensing & Sales Manager
of the new facility. and
Global Business & In-Licensing Manager
The novel engineering concept of
Detailed position profiles and online application available at LinkedIn.
the new facility meant that the fill- com.
ing line was designed without any This is a free service to a euroPLX Community Member.
format parts and based entirely
site however; sustainable clean- newly build facility project. The
on robotic vial movement. When
room panels sourced from the high quality materials ensure that
compared to conventional set up,
UK-based company MRC provide the site is extremely modern and
this novel approach means that
a seamless finish to the clean much more than just a state of
not only are set up times mini-
room, as most of the furniture the art facility for aseptic filling of
mised, but it is now possible to
and coving is built into the wall highly potent substances, where
change the format of a vial within
panels themselves. While this the complete process from com-
a batch, through use of a closed
technology is not new, Aqvida are pounding to innovative robotic
isolator; all achieved with the
the first German company to use filling is contained within isolators.
minimum of interruption, helping
this high quality material in their
to drive improvements in both
efficiency and product safety. Complimentary Advertisement of a euroPLX 64 Vienna Registrant
The robotic filling line is only one
Generic version of Iressa© available
of the innovations within the new Synthon will submit its dossier for a generic version of Iressa©
(gefitinib) upon data exclusivity expiry in June 2017. We would
like to highlight the available dossiers for the generic versions of
Tarceva© (erlotinib, currently in registration), Revlimid© (lenalidomide,
submission in July 2017) and Zytiga© (abiraterone). Synthon’s portfolio
is aimed at global out-licensing. Please contact LicensingOut.NL@
synthon.com …or discuss this opportunity with us at euroPLX 64
Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
Unique medical devices for fast market entry
Medserva® couts since 17 years for medical devices treating many
indications, offering the consumer innovative ways for self-medication
of their problems. The products are already marketed in Europe and
can be easily launched in short term. New items are for snoring,
smoking cessation, acne, infant colics and many other categories.
Please chose from the product list and contact us info@medserva.com
…or discuss this opportunity with us at euroPLX 64 Vienna!
Through this backward integra-
tion, AqVida is able to control the
value within the entire chain; from
generic development of products
and related dossiers, through reg-
istration procedures, commercial
production and finally supply of
the products. When compared to
the conventional German model
of using 3rd party contract manu-
facturing facilities, AqVida, with its
high degree of integration, truly
offers a valid and sustainable alter-
native, with unrivalled advantages,
to all companies that are seeking
oncology products.
BD People on the Move
* Adare Pharmaceuticals,
Inc.: Leonardo Sole who has
been Associate of Commercial
Development at Adare
Pharmaceuticals S.r.l. left the com-
pany on 14 April. (Pers Comm 18
Apr 2017)
* CURE Pharmaceutical : Richard
S. Serbin who previously held
the position of Vice President
of Corporate Development for
Johnson & Johnson, has been
appointed Head of Global
Corporate Development. (Press
Release 9 May 2017)
* Intact Vascular, Inc.: Howard
Rosen, who most recently
served as Vice President of the
Cell Processing Franchise at the
Haemonetics Corporation has
been hired as Vice President
of Marketing and Business
Development. (Press Release 1
May 2017)
* Sanofi: Rachel Freeman, who has
been Commercial Development
Manager at Sanofi Commercial
(UK), left the company. (Pers
Comm 18 Apr 2017)
* Therabel Pharma: Dr. Arnaud
Complainville, who has been Vice
President Business Development
and Licensing, left the company.
(Pers Comm 18 Apr 2017)
Company News successfully completed the acqui- behind a proprietary controlled-
sition of ZELTIQ® Aesthetics, Inc., cooling fat reducing treatment,
* Acquisition: Allergan plc has a medical technology company CoolSculpting®. Allergan acquired
ZELTIQ® Aesthetics for approxi-
Complimentary Advertisement of a euroPLX 64 Vienna Registrant mately $2.4 billion in cash. 28 Apr
2017 (www.allergan.com)
Looking for the best Licensing Partner?
Companies that are interested in out-licensing their products for * Acquisition: Aurobindo Pharma
successful marketing in the UK and Republic of Ireland should Limited’s 100% subsidiary, Agile
request to meet with Kent Pharmaceuticals at euroPLX Vienna. Kent
Pharmaceuticals is a leading pharmaceutical company looking to Pharma B.V, Netherlands, acquired
further strengthen both its branded and generic pharmaceutical Generis Farmacêutica S.A. from
portfolio particularly in the hospital sector. Please contact us at
steve.short@kentpharm.co.u …or discuss this opportunity with us at
Magnum Capital Partners. Generis
euroPLX 64 Vienna! is a company engaged in the man-
ufacture and sale of pharmaceuti-
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
cal products in Portugal. Closing
Generic APIs of the transaction is conditional
Minakem, part of the MINAFIN group, is a supplier of generics APIs. on obtaining necessary approvals
Our stand out products are esomeprazole and budesonide, produced
at former AstraZeneca chemical site. Minakem is willing to partner to from Portuguese authorities.The
co-develop the generic products of tomorrow. total consideration for the acquisi-
Minakem, part of the MINAFIN group, is a world leading fine tion is €135mn. The acquisition
chemical company whose core businesses are: Generic APIs, APIs and
includes the manufacturing facility
Intermediates custom manufacturing, building blocks. Please contact
Audrey.Lejeune@minakem.com …or discuss this opportunity with us in Amadora, Portugal, which has
at euroPLX 64 Vienna! the capacity to manufacture 1.2bn
tablets/capsules/sachets annually.
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
7 Jan 2017 (www.aurobindo.com)
Quality meets Science!
Intertek is an analytical contract organization offering its analytical * Acquisition: Aytu BioScience, Inc.
and material technology services to pharma and biopharmaceutical acquired Nuelle, Inc., a women’s
companies under GMP, ISO and GLP requirements. Intertek offers a
sexual health company. This trans-
wide variety of services in API and drug product development and
their packaging materials in all clinical phases and a wide range of action expands the Company’s
applications. Intertek has more than 40’000 employees worldwide. product portfolio with the addi-
Please contact stefan.heck@intertek.com …or discuss this opportunity
with us at euroPLX 64 Vienna tion of the Fiera® personal care
device for women. Fiera was
Complimentary Advertisement of a euroPLX 64 Vienna Registrant recently launched in the United
States and is a proprietary, reve-
nue-generating product scientifi-
Wide range of pharmaceutical forms cally proven to enhance physical
We are experts in the development and manufacturing of Medical arousal and sexual desire in the
Devices, functional Cosmetics, and Food Supplements and we strive
millions of adult women around
to best meet the expectations of the market in terms of health
and wellbeing in several therapeutic areas. Pharmaceutical forms the world impacted by changes in
produced: solid, liquid, aerosols and patches. Please contact info@
sexual desire. 9 May 2917 (aytubio.
nirialpharma.com …or discuss this opportunity with us at euroPLX 64
Vienna! com/)
Complimentary Advertisement of a euroPLX 64 Vienna Registrant * Acquisition: Becton, Dickinson
and Company and C. R. Bard, Inc.,
Farmak is looking for new opportunities
a medical technology leader in the
Farmak a.s., is a leading Czech FDA and EU GMP certified producer of
APIs with capable R&D activities, exporting its services and products fields of vascular, urology, oncolo-
worldwide. We look for new market opportunities in our standard gy and surgical specialty products,
API business and also in the field of FDF based on our APIs already
signed a definitive agreement
produced or under development. A close collaboration in mutual
projects is welcomed. Please contact us at www.farmak.cz …or discuss under which BD will acquire Bard
this opportunity with us at euroPLX 64 Vienna! for $317.00 per Bard common
share in cash and stock, for a total
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
consideration of $24 billion. 23
Opportunity to licence Apr 2017 (www.bd.com)
Douglas Pharmaceuticals is a New Zealand FDA and GMP certified
* Acquisition: Ipsen has completed
producer of pharmaceuticals exporting to over 35 countries. We are
looking for new markets particularly in the Eastern EU where we have its previously announced acquisi-
had limited contact to date. If you would like to have a chat about in tion of a portfolio of five consumer
licence opportunities please contact me on carlp@douglas.co.nz …or
discuss this opportunity with us at euroPLX 64 Vienna! healthcare products from Sanofi.

Complimentary Advertisement of a euroPLX 64 Vienna Registrant
Trusted Partner, Committed to Excellence
Remedica, member of the Ascendis Health group, is a European-based
group specialising in the development, production and marketing
of high quality, pharmaceutical products. It offers out-licensing
opportunities such as anticancer products and products for HIV,
hepatitis B and has pipeline consisting of more therapeutic areas.
Please contact businessdevelopment@remedica.com.cy …or discuss
this opportunity with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
Accord Healthcare
Accord is one of Europe’s fastest growing generic companies with
a marketing infrastructure in over 35 European markets covering
97% of the patient population. As market leader in UK, Irish and
Spanish Hospitals markets Accord intends to expand its marketing
portfolio with simple/complex generics and biosimilars through
product acquisition, in-licensing, distribution and other opportunities.
Please contact mmasvalls@accord-healthcare.com …or discuss this
opportunity with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
How to become the only generic for life
We have generics that are and will remain to be the only generic for
the product’s entire lifecycle. These “lifetime generics” are available for
license. Reply to us at Harvest Moon Pharmaceuticals USA or meet us
at euroPLX 64 Vienna to learn more. Be sure to read my article in this
and the next issue of the euroPLX Business Developer. Please contact
rich.dicicco@harvestmoonpharma.com …or discuss this opportunity
with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
RosenPharma - new products + CMO services
Czech company RosenPharma offers new Nitrofurantoin macrocrystals
50 and 100 mg cps. (DCP registration will start Q1 2018) dossier with
BES, Pyrvinium susp. and tabs. dossier ( West Europe countries are not
free) - OTC anthelminticum for therapy of pinworms by children and
adults and CMO of medicines, food supplements and cosmetics /tabs,
caps, eff. tabs, sachets, gels,../ in smaller batches too. Please contact
pavel_hoder@yahoo.com …or discuss this opportunity with us at
euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
We offer ready-to-market products
Giellepi SpA has developed a range of cutting-edge medical devices
and food supplements in different therapeutic areas available under
license or on private label basis. Latest developments include an
innovative approach for treating vaginal infections, a product for
digestive health, a line for pain management and a line indicated to
cough and cold. Please contact sara.dorna@giellepi.it …or discuss this
opportunity with us at euroPLX 64 Vienna!
The most significant product is sold respectively in Greece and
Prontalgine®, an analgesic for the the Republic of Ireland. 8 May
treatment of moderate to severe 2017 (www.ipsen.com)
pain, only sold in France. The port-
* Acquisition: PTC Therapeutics,
folio also includes Buscopan®, an
Inc. has completed its acquisi-
antispasmodic (sold in the Czech
tion of all rights to Emflaza™
Republic, Estonia, Hungary, Latvia,
(deflazacort) for the treatment of
Poland and Slovakia), Suppositoria
Duchenne muscular dystrophy
Glycerini, a laxative (sold in
in the U.S. Execution of the asset
the Czech Republic), as well as
purchase agreement setting forth
Mucothiol® and Mucodyne®,
the terms of the acquisition was
expectorants for cough and flu,
announced on March 16, 2017. on annual net sales of Emflaza
Financial terms of the acquisi- beginning in 2018, which PTC
tion include a total upfront con- expects will range as a percent-
sideration of $140 million paid age of net sales between the low
to Marathon Pharmaceuticals. to mid-20s on a blended average
Marathon is also entitled to basis. In addition, Marathon has
receive payments from PTC based the opportunity to receive a single
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
NOVENTURE Medical Devices
Noventure is specialized in Medical Devices with a unique technology
based on the “barrier-effect”. Products are available for out-licensing
within the EU and associated countries under the CE mark certification.
Already present in more than 40 countries. Check if your territory
is available! Our areas are Gastroenterology, Uro-gynaecology,
Paediatrics & Allergy. Please contact llorenzo@noventure.com …or
discuss this opportunity with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
The probiotic most studied in the world
VSL Pharma is focused on the development of products based on
the technological platform of probiotic bacteria for use as food
supplement. With more than 170 scientific articles published, VSL#3
is the best in class for dietary management. VSL#3 has different SKU
from 45 to 900 bill of beneficial live bacteria. VSL Pharma is looking for
licensing out in some markets not covered yet. Please contact info@
vsl3pharma.com …or discuss this opportunity with us at euroPLX 64
Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
Contract Packaging for the Pharma Sector
Millmount Healthcare is HPRA, FDA & ANVISA approved. We offer
Primary and Secondary packaging with versatile lines to support
quick changeovers & small to large scale batch sizes. Our Serialisation
technology is an illustration of the strategic & operational investment
in our capabilities, showing commitment to changing market & supply
chain needs. Please contact ncunningham@millmount.com …or
discuss this opportunity with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
Frike Group, your CMO partner
We offer our excellence service reliability for your needs and success.
As a full service CMO we are experts for manufacturing semi solids,
fluids and suppositories, including packaging. Please contact info@
glaropharm.ch or walter.salvadori@frike-group.com …or discuss this
opportunity with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
New wound care products
SastoMed is the place where research in the field of modern wound
care reaches its limits. We produce and offer high sophisticated wound
care products for chronic up to difficult to heal wounds. We are present
in 40 countries worldwide and seeking for new territories through
distributors to introduce our top products. In case you are interested,
please visit our website at sastomed.de or contact f.maes@sastomed.
de …or discuss this opportunity with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
AOP Orphan in- and out-licensing
As a leader in the sector of rare diseases, AOP develops and
commercializes innovative solutions in the areas of hematology/
oncology, cardiology/pulmonology, neurology/psychiatry/metabolic
diseases. AOP is interested in partners for the distribution of AOP
products as well as in-licensing late stage products as well as active
ingredients in the mentioned therapeutic areas for the distribution
within Europe. Please contact partnering@aoporphan.com …or discuss
this opportunity with us at euroPLX 64 Vienna!
$50 million sales-based milestone. eutics, Inc.’s subsidiary, Levena
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
20 Apr 2017 (www.ptcbio.com) Biopharma Co., Ltd., has complet-
ed construction and put into oper- Ready MAs in EU for fast acting Ibuprofen
* Distribution and Supply:
ation a 25,000 square foot Good Great opportunity for OTC portfolio broadening with ready Marketing
Santhera Pharmaceuticals has Authorizations across EU for Ibuprofen Lysine 342 mg. Ibuprofen is
Manufacturing Practice (GMP)
signed an agreement with more rapidly absorbed administered as Ibuprofen lysine. Extension of
manufacturing facility in Suzhou,
Pharmathen to market Raxone® for an Ibuprofen portfolio is possible by being marketed as rapid, forte
China. The facility will be fully etc. MA transfer can be done immediately hence quick market entry.
the treatment of Leber’s heredi- Please contact business.development@alkaloid.com.mk …or discuss
dedicated to supporting Sorrento’s
tary optic neuropathy (LHON) in this opportunity with us at euroPLX 64 Vienna!
antibody drug conjugate (ADC)
Greece and Cyprus. LHON is a rare,
pipeline and growing service busi- Complimentary Advertisement of a euroPLX 64 Vienna Registrant
heritable, mito-chondrial disease
ness. 4 May 2017 (www.sorrento-
that leads to rapid, profound and Taking Pharma to New Heights
therapeutics.com)
usually permanent blindness EirGen Pharma, part of Miami based OPKO Health, offers world class
pharmaceutical development and commercial supply from our purpose
in other-wise healthy patients. * Acquisition: Sosei Group Cor­
built globally approved high containment facility. Licensed specifically
Raxone is the first treatment pora­tion and MiNA Therapeutics to handle molecules which require containment and currently
option for LHON and the first Limited have entered into a investing in a state of the art fill finish facility, we export product to
over 50 countries from our expanding campus. Please contact bd@
approved therapy for a mitochon- definitive agreement under which eirgen.com …or discuss this opportunity with us at euroPLX 64 Vienna!
drial disease. 2 May 2107 (www. Sosei will make an investment in
santhera.com) and acquire an exclusive option Complimentary Advertisement of a euroPLX 64 Vienna Registrant
to potentially acquire MiNA
* Investment: Sorrento Therap­
Therapeutics, a private UK biop- Seeking Partners for Product Licensing
AJA Pharma is seeking partners to license Products for GCC Region
that also includes innovative and value added products with high
Complimentary Advertisement of a euroPLX 64 Vienna Registrant potential in varied therapeutic areas. AJA is a manufacturing and
marketing company having robust local regulatory and commercial
structure and a state-of-the-art, approved GMP manufacturing facility
Idifarma - CDMO for highly potent FDF located in Hail, Saudi Arabia. Please contact info@ajapharma.com …or
discuss this opportunity with us at euroPLX 64 Vienna!
Are you looking for a reliable and competitive European CDMO for
the development of your new products? Do you need a flexible
CMO for niche products? Are you searching for a development or Complimentary Advertisement of a euroPLX 64 Vienna Registrant
manufacturing provider for cytotoxics? Do you need GMP packaging
for your clinical trials? Or maybe a partner for the QP release of your Delorbis Pharmaceuticals Ltd
products in the EU? Please contact mleal@idifarma.com …or discuss We are a leading branded generic company that offers a broad
this opportunity with us at euroPLX 64 Vienna! portfolio of high quality pharmaceutical products to millions of people
all over the world. Our Contract Manufacturing allows small batch
size production, fast delivery & flexibility when it comes to volume
Complimentary Advertisement of a euroPLX 64 Vienna Registrant & scheduling. Learn more about what we can offer you at www.
delorbispharma.eu because at DELORBIS it’s not about us, it’s about
Your Integrated API to ANDA Partner! you. Please contact delorbis@delorbispharma.eu …or discuss this
opportunity with us at euroPLX 64 Vienna!
Enaltec is a leading end to end pharmaceutical product development
services provider. We offer API Development & Manufacturing,
Formulation & Dossier Development (viz Oral Solids & Liquids, Complimentary Advertisement of a euroPLX 64 Vienna Registrant
Injectables, Semi Solids, Opthalmics & Potent Products). Through our
flexible business models we cater to various clients across the globe.
Please contact vrushali.wadwalkar@enaltec.com …or discuss this
opportunity with us at euroPLX 64 Vienna! R-Pharm Germany GmbH - Full Service CDMO
With more than 40 years of manufacturing heritage, R-Pharm Germany
Complimentary Advertisement of a euroPLX 64 Vienna Registrant (CDMO) is producing and packaging medical and nutritional products.
We provide top-notch facilities and expertise to ensure safe and fully
automated High Containment Solid Manufacturing, along with all
Elpen | New Products market requirements for Serialization. Moreover, we are looking for in
As the #1 IMS ranked Greek pharmaceutical company, we offer licensing opportunities for oncology products and food supplements.
Respiratory, Cardio, CNS, Antimicrobials and OTC products. We Please contact andreas.wagner@r-pharm.com …or discuss this
have ready to transfer MAs across Europe for Amlodipine/Valsartan, opportunity with us at euroPLX 64 Vienna!
Irbesartan, Aripiprazole, Cilostazol, Pregabalin and Rosuvastatin. New
Products: ROSUVASTATIN/EZETIMIBE (own development & production); harmaceutical company and pio- Torrent Pharma, has completed
AMLODIPINE/ATORVASTATIN/HCTZ (on-going DCP). Please contact neer in RNA activation therapeu- the acquisition of Regestrone and
a.vazquez@elpen.gr …or discuss this opportunity with us at euroPLX
64 Vienna! tics (small activating RNAs, saR- Pregachieve brands for India from
NAs). Sosei will make an upfront Novartis AG, Switzerland. These
Complimentary Advertisement of a euroPLX 64 Vienna Registrant strategic investment of GBP 35 brands are widely prescribed by
million into MiNA Therapeutics Gynaecologists for the manage-
GENEPHARM, best partner for in-licensing
Genepharm S.A offers a wide variety of generic eCTD dossiers
in return for a 25.6% equity share ment of Abnormal Uterine bleed-
covering various therapeutic areas. Most recent developments and an exclusive option to poten- ing, Peri & Post- menopausal
include products for hypertension or diabetes treatment such tially acquire MiNA Therapeutics. 3 symptoms and Infertility. 8 May
as Olmesartan+Amlodipine+HCT and Vildagliptine+Metformine.
Genepharm’s eCTD dossiers, including Vildagliptin, Lacosamide May 2017 (www.sosei.com) 2017 (www.torrentpharma.com)
and Rivaroxaban, are ready for submission in most regions around
the globe. Please contact bd@genepharm.com …or discuss this * Acquisition: Ahmedabad based
opportunity with us at euroPLX 64 Vienna!
euroPLX Newcomers to
euroPLX 64 Vienna (3)
Since 22 years euroPLX is attended
by companies that have never had
a delegate at any of the previous
euroPLX Conference. See who will
attend a euroPLX Conference for
the first time:
2care4 Generics (2care4generics.
dk) is based in Esbjerg, Denmark,
and specialises in the develop-
ment, registration and marketing
of generic RX medicinal products
for the Nordic markets. It has a
rapidly expanding portfolio across
a wide range of therapeutic areas
Based in Budapest, Hungary, Béres
Pharmaceuticals Ltd. (www.beres.
hu) is a family-owned company
producing and distributing nearly
80 different OTC drugs and dietary
supplements.
Enorama Pharma (www.eno-
rama.se/en/) is based in Malmö,
Sweden, and develops and sells
consumer-friendly medicated
chewing gum containing proven
drug substances, and to offer
these as private label products,
which means that the retailer mar-
kets and sells the product under
their own brand.
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
UNOLAB – CMO for Sterile Monodose in BFS
UNOLAB offers the most advanced technology for sterile unidose
format products. Following GMPs, we develop our customer needs
with a full service experience. We will help you to create your product,
manufacturing and all the support needed in the registering and
validation process. For private label distributors, we provide CE
Marks in pediatrics, inhalation and eye care areas. Please, ask for our
Portfolio. Please contact sales@unolab.es …or discuss this opportunity
with us at euroPLX 64 Vienna!
Complimentary Advertisement of a euroPLX 64 Vienna Registrant
Medicated chewing gum
Enorama Pharma develops and supplies medicated chewing gums
based on a unique compressed gum technology. We are searching for
in-licensing partners for our nicotine gum and development partners
interested in our Chewmed platform. The compressed gum technology
can facilitate drug delivery of multiple APIs where buccal delivery is
preferable. Please contact eric.sandrup@enorama.se …or discuss this
opportunity with us at euroPLX 64 Vienna!

distributed via pharmacies and Based in Moscow, Russia,

NovaMedica (novamedica.com) is Complimentary Advertisement of a euroPLX 64 Vienna Registrant
hospital tenders in Denmark,
Sweden, Norway and Finland. a venture capital backed start-up ABDI IBRAHIM is seeking in-licensing options
that has developed a well-estab- We focus on developing and utilizing opportunities in in-licensing, co-
marketing and production services in order to develop the company’s
Complimentary Advertisement of a euroPLX 64 Vienna Registrant product portfolio. As the in-licensing model, (through finished
product/technology business model), oncology, metabolism (osteopor
Putting Silicium in the Heart of Your Strategy osis,diabetes,obesity), immune system, ophthalmology, cardiovascular
Eytelia is the European reference for food supplements, nutricosmetics system, respiratory system and OTC are the main areas. Please contact
and cosmetic gels based on Organic Silicium bio-activated. We cem.yurdakul@abdiibrahim.com.tr …or discuss this opportunity with
make it our business to offer you a tailor-made approach to develop us at euroPLX 64 Vienna!
innovative products which will give your product range a competitive
edge. We are interested in Private label contracts for small, medium Complimentary Advertisement of a euroPLX 64 Vienna Registrant
to large batches. Please contact c.willaert@eytelia.eu …or discuss this
opportunity with us at euroPLX 64 Vienna! Strategic Partnership Sought
BÉRES PHARMACEUTICALS (www.beres.hu) are looking for partners
Complimentary Advertisement of a euroPLX 64 Vienna Registrant worldwide to out license its products from its own R&D, offering
contract manufacturing capacity. Our calcium and vitamin D3
Excellence in generics combination product CalciviD has MRP license in a number of EU
countries. Should you be interested in any of our products, please
Unipharm is a leading generic Israeli company and EU GMP certified
contact hornyanszky.adam@beres.hu …or discuss this opportunity
producer with 40 years of experience. We offer a wide product
with us at euroPLX 64 Vienna!
portfolio for all major therapeutic areas. We look for new market
opportunities through L&S agreements. Unipharm new state of the art
OSD facility will start to operate before the end of 2017 and can serve Complimentary Advertisement of a euroPLX 64 Vienna Registrant
all markets with up to date instruments and regulatory standards.
Please contact bd@unipharm.co.il …or discuss this opportunity with We turn challenges in to opportunities
us at euroPLX 64 Vienna! Growing fast and making an impact for patients in emerging markets.
With a clear focus on selected markets in the Middle East, Africa,
Complimentary Advertisement of a euroPLX 64 Vienna Registrant the CIS Region, and Latin America, we are operating in some of the
most dynamic countries of the world. Our in-depth knowledge of our
DSP is looking for new opportunities markets enables us to adapt to local needs, however challenging. Find
out more on www.acino.swiss …or discuss this opportunity with us at
We are a B2B provider of Active Pharmaceutical Ingredients and
euroPLX 64 Vienna!
generic Drug Products. What sets DSM Sinochem Pharmaceuticals
(DSP) apart is our full backward integration and control of our supply
chain. Based on our vertically integrated production capabilities and
lished infrastructure to develop natural sources using innovative
paired with our extensive regulatory know-how, doing business with and commercialize pharmaceuti- technologies.
DSP enables you to focus on what truly counts: your business and your cals with a current portfolio which
customers. Please contact licensing@dsm-sinochem.com …or discuss RN Laboratories AG (www.chlo-
this opportunity with us at euroPLX 64 Vienna! includes 25 products in ophthal-
rhexidine.ch) is headquartered
mology and gastroenterology.
Complimentary Advertisement of a euroPLX 64 Vienna Registrant in Sarnen, Switzerland, and is the
With its head office in Mumbai, exclusive distributor of chlorhex-
India, OmniActive Health idine and it’s salts in Europe deliv-
Venture Life: new finished products
Venture Life, an UK pharma Company dedicated to R&D of innovative
Technologies (www.omniactives. ering out of 3 warehouses located
Medical Devices, Food Supplements and Cosmetics has just finalized com) is s spin-off of a well estab- in Europe.
development of new products, Mycoclear (nails fungi treatment), lished natural ingredients and
Rosacalma (acne rosacea), ready to be out-licensed. Ultradex (full Being part of the Darling
line for treatment halitosis), Vonalei (full range for women diseases), spice producer. The company
Proctoeze (hemorrhoids), Benecol (anti-cholesterol), Neuroage Ingredients Group, the Dutch
develops IP -protected, science
(memory). Please contact fbianchi@venture-life.com …or discuss this Rousselot BV (www.rousselot.
opportunity with us at euroPLX 64 Vienna!
-backed branded ingredients from
com) aims to be the global leader
of gelatin and collagen peptides
for uses in the fields of pharma,
food, healthy nutrition and natural
beauty.
So.Se.PHARM Srl (www.sosep-
harm.com) is a family-run phar-
maceutical company in Pomezia
(Rome), Italy, which markets
generic prescription drugs with
its own brand name, OTC medi-
cines and branded products for
health care and personal hygiene
throughout Italy with an own sales
and distribution network, and in
43 further countries through a
network of licensees and distri-
bution agreements with foreign
companies.
Vésale Pharma International
(www.vesalepharma.com) is
located close to the Belgian capital
of Brussels and specialises on the
development of innovative probi-
otic solutions, but also markets a
range of products in dermatology,
gastroenterology, women’s health,
immunity and pregnancy.

Insanely Effective
Pharma Partnering
euroPLX is the world’s most often held
partnering conference for the pharma
and biopharma industries.
Regis

Because of results delivered. Year-round.

ter o

Join the 65th International Partnering

n
line:

Conference for Pharma Business Development

www

euroPLX 65 London (UK)

.euro

November 27 + 28, 2017, Sofitel London Heathrow

plx.c

Seeking and offering business opportunities in patented and generic (incl.

biosimilars), prescription and OTC drugs, medical devices, and nutraceuticals -
om

development, licensing, marketing, promotion, and distribution…

Each euroPLX Conference’s actual collaboration interests are summarised and
displayed on www.europlx.com as an hourly updated Dynamic Partnering
Focus, as soon as sufficient data are submitted by registrants.

www.europlx.com
meetyou@europlx.com
The Original since 1995.
ph. ++49 (6221) 426296-0 Often copied. Never equaled.